All In Biotech

Drug Trial Radar · NCT06740526

Phase 2b Open-Label Repeat Kidney Biopsy Study

A Phase 2b, Multicenter, Open-label, Single-arm Trial to Evaluate the Impact of Sibeprenlimab on Kidney Histopathology Through Repeat Kidney Biopsies Adults With Immunoglobulin A Nephropathy

Last checked: Nov 20, 2026Latest source record: Oct 27, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

Active, not recruiting

Status

Active, not recruiting

Enrollment

56

Actual

Start

Dec 5, 2024

Primary completion

Dec 28, 2028

Study completion Dec 28, 2028

Sponsor

Sponsor type
Industry
First posted
Dec 18, 2024

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 2
Allocation
Not applicable (single group)
Model
Single group
Masking
None
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

Assess impact of sibeprenlimab on IgA deposition and other histological endpoints in kidney tissue at Week 52 relative to baseline

Conditions

  • IgA Nephropathy

Interventions

  • SibeprenlimabDrug

    Sibeprelimab SC (Period 1) Sibeprelimab SC (Period 2)

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Change from Baseline in Glomerular IgA Deposition by Immunofluorescence in Kidney Tissue to Week 52Time frame: From Baseline to Week 52

Locations

19 sites in 5 countries. Site status is shown where the registry gives one.

  • University of Alabama at Birmingham

    Birmingham, Alabama

  • Stanford University Medical Center

    Stanford, California

  • Colorado Kidney Care PC

    Denver, Colorado

  • Massachusetts General Hospital (MGH) Harvard

    Boston, Massachusetts

  • Dakota Dunes

    Dakota Dunes, South Dakota

  • Prolato Clinical Research Center

    Houston, Texas

  • Hospital Britanco de Buenos Aires

    Buenos Aires, Argentina

  • Centro Medico Dra Laura Maffei- Investigacion Clinica Aplicada

    Buenos Aires, Argentina

  • St. Paul's Hospital

    Vancouver, British Columbia, Canada

  • Hamilton Centre for Kidney Research (HCKR)

    Hamilton, Ontario, Canada

  • OTT Healthcare

    Scarborough Village, Ontario, Canada

  • Kyushu University Hospital

    Fukuoka, Japan

  • University of Miyazaki Hospital

    Miyazaki, Japan

  • Juntendo University Hospital

    Tokyo, Japan

  • Juntendo University - Urayasu Hospital

    Urayasu, Chiba, Japan

  • Kobe University Hospital

    Kobe, Hyōgo, Japan

  • Nara Medical University Hospital

    Kashihara, Nara, Japan

  • Leicester General Hospital

    Leicester, United Kingdom

  • King's College Hospital NHS Foundation Trust

    London, United Kingdom

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.